Quarterly Result23 May 2026, 05:01 pm
Sai Parenterals: FY26 Audited Results Approved
AI Summary
Sai Parenterals Ltd. announced the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, during a board meeting held on May 23, 2026. The board also approved the unaudited financial results and limited review report for the quarter and nine months ended December 31, 2025. M/s. R Kabra & Co. LLP issued an unmodified opinion on the audited financial results.
Key Highlights
- Audited financial results (standalone and consolidated) approved for the year ended March 31, 2026.
- Unaudited financial results (standalone and consolidated) approved for quarter and nine months ended December 31, 2025.
- Auditors issued an unmodified opinion on the FY26 audited financial results.
- Revenue from Operations ₹384.79 Million for the quarter ended Dec 31, 2025.
- Profit after tax ₹3.6 Million for the quarter ended Dec 31, 2025.
Price Impact
More from SAIPARENT